Seer, Inc.

SEER

$1.94

-2.02%

N/A-$0.04

Healthcare

Biotechnology

NASDAQ

Active Trading

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. ...

Key Metrics of SEER

Snapshot

Latest / TTM · 6 periods

Market Cap

$106.66M

ROCE

-28.9%

EV / EBITDA

-1.60x

-1.1% YoY

FCF Yield

-41.5%

+2.5% YoY

Cash Conversion Cycle

311.4d

Current Ratio

14.74

Quick take

TTM —

Positive CCC

Key Metrics

Latest / TTM · 6 periods

Valuation trend

Valuation trend table

Metric	2021	2022	2023	2024	2025	TTM
Market CapTotal market value of all shares outstanding.	$1.39B	$362.11M	$123.87M	$144.02M	$105.13M	$106.66M
Enterprise ValueCompany value including debt and cash adjustments.	$1.18B	$338.78M	$119.63M	$129.23M	$81.50M	$102.98M
EV / SalesHow many dollars investors pay per dollar of sales.	184.36x	23.07x	7.88x	9.27x	5.06x	7.44x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	-17.44x	-3.89x	-1.48x	-1.61x	-1.13x	-1.60x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	3.10	0.27	0.05	0.18	0.33	0.06

Returns + ROCE gauge

ROCE latest

-28.9%

Prev year -27.8%

Returns + ROCE gauge table

Metric	2021	2022	2023	2024	2025	TTM
ROEProfit generated from shareholders' equity.	-14.2%	-20.8%	-21.7%	-26.4%	-28.4%	-27.2%
ROAProfit generated from total assets.	-13.2%	-19.1%	-19.8%	-23.6%	-24.9%	-26.5%
ROICReturn generated on invested operating capital.	-16.5%	-19.8%	-23.7%	-31.0%	-35.4%	-36.9%
ROCEOperating return on long-term capital used.	-13.6%	-20.6%	-24.8%	-28.5%	-27.8%	-28.9%
Earnings YieldEarnings as a percentage of market value.	-5.1%	-25.7%	-69.7%	-60.1%	-70.0%	-63.5%

Cash flow quality

Cash flow quality table

Metric	2021	2022	2023	2024	2025	TTM
FCFFCash flow available to all capital providers.	$-53.25M	$-71.05M	$-66.37M	$-49.69M	$-46.24M	$-44.23M
FCFECash flow available to equity holders after debt flows.	$-53.27M	$-71.05M	$-66.37M	$-49.69M	$-46.24M	$-44.23M
FCF YieldFree cash flow divided by market capitalization.	-3.8%	-19.6%	-53.6%	-34.5%	-44.0%	-41.5%
Income QualityHow well accounting earnings are backed by cash flow.	0.65	0.65	0.68	0.53	0.60	0.64
Capex / OCFShare of operating cash flow spent on capital expenditures.	-14.9%	-16.9%	-12.4%	-7.8%	-4.0%	-2.0%

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	TTM
DSOAverage days to collect cash from customers.	236.6d	174.4d	161.5d	163.0d	134.8d	90.4d
DIOAverage days inventory stays before being sold.	223.5d	118.1d	119.4d	381.5d	350.7d	376.1d
DPOAverage days the company takes to pay suppliers.	204.3d	53.7d	36.4d	237.1d	252.4d	155.2d
Operating CycleTime from buying inventory to collecting receivables.	460.1d	292.5d	280.8d	544.5d	485.5d	466.6d
Cash Conversion CycleNet days cash is tied in operations.	255.8d	238.8d	244.4d	307.4d	233.0d	311.4d

Snapshot

Latest / TTM: —

Market Cap

$106.66M

ROE

-27.2%

FCF Yield

-41.5%

Current Ratio

14.74

Supply Chain of SEER

Upstream / Downstream / Proxies

Upstream

Hamilton CompanyThermo Fisher Scientific Inc.NYSE:TMO Bruker CorporationNASDAQ:BRKRMerck KGaA (MilliporeSigma)XETRA:MRKVarious precision component suppliers to Hamilton Company

Downstream

PrognomiQ, Inc.Academic and Research InstitutionsPharmaceutical and Biotechnology CompaniesThermo Fisher Scientific Inc.NYSE:TMO Bruker CorporationNASDAQ:BRKRContract Research Organizations (CROs)

Proxies

Bio-Rad Laboratories, Inc.NYSE:BIO Waters CorporationNYSE:WAT Quanterix CorporationNASDAQ:QTRX Standard BioTools Inc.NASDAQ:LAB

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer